<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel rdf:about="http://hdl.handle.net/123456789/1956">
<title>ANTIDIABETIC AND HEPATO-RENAL PROTECTIVE EFFECTS OF ETHYL ACETATE FRACTION OF METHANOL LEAF EXTRACT OF Solanum macrocarpon Linn IN STREPTOZOTOCIN-INDUCED DIABETIC MALE WISTAR RATS</title>
<link>http://hdl.handle.net/123456789/1956</link>
<description/>
<items>
<rdf:Seq>
<rdf:li rdf:resource="http://hdl.handle.net/123456789/1957"/>
</rdf:Seq>
</items>
<dc:date>2026-04-19T22:52:06Z</dc:date>
</channel>
<item rdf:about="http://hdl.handle.net/123456789/1957">
<title>ANTIDIABETIC AND HEPATO-RENAL PROTECTIVE EFFECTS OF ETHYL ACETATE FRACTION OF METHANOL LEAF EXTRACT OF Solanum macrocarpon Linn IN STREPTOZOTOCIN-INDUCED DIABETIC MALE WISTAR RATS</title>
<link>http://hdl.handle.net/123456789/1957</link>
<description>ANTIDIABETIC AND HEPATO-RENAL PROTECTIVE EFFECTS OF ETHYL ACETATE FRACTION OF METHANOL LEAF EXTRACT OF Solanum macrocarpon Linn IN STREPTOZOTOCIN-INDUCED DIABETIC MALE WISTAR RATS
ANJORIN, Oluwasegun Joseph
Diabetes mellitus (DM), a metabolic disease, is becoming more prevalent globally. Solanum&#13;
macrocarpon (Linn.) is traditionally used in the treatment of DM but there is paucity of&#13;
information on the scientific evaluation of its diabetic activity. The aim of this study was to&#13;
evaluate the antidiabetic activity of the methanol leaf extract of Solanum macrocarpon in&#13;
streptozotocin-induced diabetic male Wistar rats.&#13;
Solanum macrocarpon leaves were air-dried, pulverised, extracted with methanol (SME) and&#13;
then fractionated into n-hexane, chloroform, ethyl acetate (EA), n-butanol and methanol.&#13;
Phytochemical screening and antioxidant [Total flavonoids content, 2,2 diphenyl-1-&#13;
picryhydrazl reduction (DPPH), Total Antioxidant Capacity (TAC), and Reducing Power&#13;
(RP)] activity were evaluated in SME and its fractions while α-amylase inhibition (α-AI), α-&#13;
glucosidase inhibition (α-GI), Metal Chelating (MC) and Nitric Oxide (NO) scavenging&#13;
activities were evaluated in SME only by spectrophotometry. Diabetes mellitus was induced&#13;
using streptozotocin (50mg/kg i.p.) and animals with fasting blood glucose (FBG) ≥&#13;
250mg/dL were considered as being diabetic. Twenty-four rats (139-146g) were grouped&#13;
(n=6): Groups 1 (control), 2 (diabetic control), 3 (diabetic rats + EA fraction, 300mg/kg) and&#13;
4 (diabetic rats + Glibenclamide, 1mg/kg) and treated orally for 28 days. The animals were&#13;
sacrificed and FBG, Oral Glucose Tolerance Test (OGGT), glycated haemoglobin, urea,&#13;
creatinine, Alkaline Phosphatase (ALP), Glutathione Peroxidase (GPx), Aspartate&#13;
Transaminase (AST), Superoxide Dismutase (SOD), and levels of GSH and malondialdehyde&#13;
were assessed by spectrophotometry. Histological examinations of the liver and kidney were&#13;
performed using standard procedures. Chemical profiling of EA fraction was determined&#13;
using Fourier Transformed Infrared (FT-IR) spectroscopy and GC-MS. Data were analysed&#13;
using descriptive statistics and ANOVA at α0.05.&#13;
The presence of alkaloids, saponins, phenols, flavonoids, steroids, and terpenoids were&#13;
detected in SME and its fractions. Antidiabetic activity analysis showed that SME exhibited&#13;
α-AI (59.9%) and α-GI (41.7%) activities. The SME also exhibited NO scavenging (77.4%)&#13;
and MC (48.8%) activities as well as TAC (0.021mg/gAAE). The EA fraction possessed the&#13;
highest total flavonoids (0.23mg/gQUE), TAC (0.05 mg AAE/g) and DPPH (92.6%)&#13;
scavenging activity. In diabetic rats+EA fraction, body weight (36.5%) increased, while&#13;
decrease in FBG (60%), OGTT and glycated haemoglobin decreased relative to control was&#13;
observed. Creatinine (28.2%), urea (18.5%), AST (16.3%), ALT (20%), and ALP (31.1%)&#13;
were reduced in diabetic rats+EA fraction relative to diabetic controls. Activities of SOD&#13;
(0.104 vs 0.128 units/mg protein), CAT (0.121vs 0.155units/mg protein), and GPx (8.59 vs&#13;
10.17 units/mg protein) as well as GSH level (2.66 vs 3.64 µmol/L) elevated in the diabetic&#13;
rats+EA fraction compared with diabetic. Malondialdheyde levels (26.7%) reduced relative to&#13;
diabetic control. The diabetic rats+EA fraction showed reversal of hepatic and renal periportal&#13;
inflammatory infiltration observed in the diabetic controls. Presence of hydroxy groups in EA&#13;
fraction (3500 cm-1) was revealed, and squalene intermediates as the most abundant&#13;
compounds.&#13;
The ethyl acetate fraction of Solanum macrocarpon ameliorated hyperglycaemia and&#13;
protected renal and hepatic tissues through antioxidant mediated mechanisms in&#13;
streptozotocin-induced diabetic rats.
</description>
<dc:date>2023-12-01T00:00:00Z</dc:date>
</item>
</rdf:RDF>
